The first controlled study of the use of lysergic acid diethylamide as part of psychotherapy in more than 40 years found it may help reduce anxiety in patients with terminal illness, according to Swiss investigators. Researchers writing in the Journal of Nervous and Mental Disease said the results of the 12-person pilot study, in which eight patients received LSD, warrant larger controlled trials.

Related Summaries